ARCHIVES

No Difference in Toxicity Between IMRT and PRT In Medicare Patients

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

DCPC Board Approves Nine Concepts, New Small Cancer Control Grants, Rerelease Of FDA For Nutrition Core Grants

January 20, 1984

New ACS Structure Proposed, approved

August 6, 1993

Osteoporosis Treatments Associated With Decreased Risk Of Breast Cancer

March 26, 2010

Bristol-Myers Squibb Board Removes CEO Peter Dolan Over Plavix Deal. Two Republican Senators Say They Will Place Holds On Confirmation of Andrew von Eschenbach as FDA Commissioner. Craig Thompson Named Director of Abramson Cancer Center.

September 15, 2006

MIT Radiation Poisoning Was Deliberate, NRC Investigation Finds

December 15, 1995

NCAB Committee Reaches Consensus On Organ Systems; DeVita Goes Along

February 4, 1983